Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: a modelling studyResearch in context

Summary: Background: As of the end of 2021, twenty-four countries in the African meningitis belt have rolled out mass campaigns of MenAfriVac®, a meningococcal A conjugate vaccine (MACV) first introduced in 2010. Twelve have completed introduction of MACV into routine immunisation (RI) schedules. A...

Descripció completa

Dades bibliogràfiques

Autors principals:	Rose G. Bender, Jasmine Shen, Aleksandr Aravkin, André Arsène Bita Fouda, Ado M. Bwaka, Natalie C. Galles, Emily Haeuser, Simon I. Hay, Anderson Latt, Jason M. Mwenda, Emma L.B. Rogowski, Alyssa N. Sbarra, Reed J.D. Sorensen, Avina Vongpradith, Claire Wright, Peng Zheng, Jonathan F. Mosser, Hmwe H. Kyu
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2023-02-01
Col·lecció:	EClinicalMedicine
Matèries:	Meningitis MenAfriVac Meningococcal vaccination Meningitis belt Vaccination coverage Meningococcal disease
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2589537022005260
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!